Sign in
4

Changes in Ownership

CNS Pharmaceuticals, Inc. Filed Acc 0001683168-22-001545

Director acquired 3,750 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Evans Carl Anthony · Director

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2022-03-08 Grant or award : show line 1 in the form +3,750 $0.27 $1,005 3,750 D
Loading xslF345X03/ownership.xml…